Is an ANC of 1,474 cells/µL Normal for a 44-Year-Old Male of African Descent?
An absolute neutrophil count of 1,474 cells/µL is normal for a 44-year-old male of African descent and requires no intervention. This value falls within the established reference range for individuals with the Duffy-null phenotype, which is present in approximately 67% of people of African ancestry and results in consistently lower neutrophil counts without any increased infection risk or adverse health outcomes.
Understanding Duffy-Null Associated Neutrophil Counts
The Duffy-null phenotype is present in 66.7% of Black individuals and causes a median ANC of 2,820 cells/µL compared to 5,005 cells/µL in Duffy non-null Black individuals. 1
Multinational reference intervals for healthy Duffy-null adults demonstrate consistent lower ranges across continents: USA (1,210–5,390 cells/µL), UK (1,185–5,462 cells/µL), Namibia (820–6,370 cells/µL), and Saudi Arabia (1,140–5,290 cells/µL). 2
An ANC of 1,474 cells/µL falls comfortably within all established Duffy-null reference ranges and represents a normal physiologic variant, not pathologic neutropenia. 2, 1
The traditional lower limit of 1,500 cells/µL was never scientifically validated and inappropriately applies European-ancestry norms to all ethnic groups, leading to systematic misclassification of 21.7–50.9% of healthy Duffy-null individuals as "neutropenic." 2, 3
Clinical Significance and Infection Risk
Duffy-null individuals with ANCs between 1,000–1,500 cells/µL have no increased susceptibility to infection and maintain normal bone marrow reserve capacity to produce neutrophils when needed. 3, 4
The critical threshold for infection risk in African Americans is an ANC below 1,100 cells/µL, not 1,500 cells/µL—this lower cutoff was identified as the prognostically relevant marker for increased mortality in a multiethnic cohort of 27,760 elderly subjects. 5
An ANC of 1,474 cells/µL is well above the 1,100 cells/µL threshold that signals true pathologic neutropenia in individuals of African descent. 5
When to Investigate Further
No workup is indicated for this patient unless any of the following red flags are present:
Fever (single temperature ≥38.3°C or sustained ≥38.0°C for ≥1 hour), which would trigger evaluation for febrile neutropenia regardless of baseline ANC. 6
Clinical signs of infection such as hemodynamic instability, altered mental status, respiratory distress, or focal infection symptoms. 6
Concurrent cytopenias (anemia or thrombocytopenia) suggesting bone marrow failure rather than benign ethnic variation. 7
Recent chemotherapy, immunosuppressive therapy, or medications known to cause neutropenia (e.g., clozapine, peginterferon-alpha). 6
Progressive decline in ANC on serial measurements, which would distinguish acquired neutropenia from stable Duffy-null physiology. 6
Common Pitfalls to Avoid
Do not order bone marrow biopsy, hematology referral, or extensive immunologic workup for an isolated ANC of 1,474 cells/µL in an asymptomatic patient of African descent—this represents overdiagnosis driven by inappropriate reference ranges. 2, 3
Do not withhold chemotherapy or other treatments based solely on an ANC of 1,474 cells/µL in a Duffy-null individual, as this perpetuates health inequities and denies effective therapy. 2, 8
Do not label this as "benign ethnic neutropenia"—the preferred terminology is "Duffy-null associated neutrophil count" to avoid stigmatizing language and accurately reflect the genetic basis. 1, 4
Do not apply the 1,500 cells/µL threshold universally—race-specific reference intervals must be used in populations with >10–20% African ancestry to prevent systematic misdiagnosis. 9
Practical Management
Reassure the patient that this ANC is normal for his genetic background and does not indicate disease or increased infection risk. 3, 4
Document Duffy-null status in the medical record to prevent future unnecessary investigations and ensure appropriate ANC thresholds are applied if the patient requires chemotherapy or other myelosuppressive treatments. 8
No routine monitoring is required unless the patient develops symptoms of infection, starts medications that affect neutrophil counts, or shows declining trends on serial CBCs obtained for other indications. 6
If future chemotherapy is planned, use Duffy-specific ANC thresholds: consider holding therapy only if ANC falls below 1,000 cells/µL (not 1,500 cells/µL), and implement prophylactic antimicrobials only when ANC drops below 500 cells/µL with expected duration >7 days. 6, 8